|
NGRN expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.63913368725844E-14 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.73017156157584E-12 |
| Normal-vs-Stage2 |
2.58426613441998E-12 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
7.684200E-03 |
| Stage1-vs-Stage2 |
2.628000E-01 |
| Stage1-vs-Stage3 |
7.082000E-03 |
| Stage1-vs-Stage4 |
4.900400E-01 |
| Stage2-vs-Stage3 |
4.301400E-01 |
| Stage2-vs-Stage4 |
3.043400E-01 |
| Stage3-vs-Stage4 |
1.811550E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.65534252971611E-12 |
| Normal-vs-AfricanAmerican |
5.4578999997279E-07 |
| Normal-vs-Asian |
2.432500E-04 |
| Caucasian-vs-AfricanAmerican |
1.336180E-02 |
| Caucasian-vs-Asian |
2.725800E-01 |
| AfricanAmerican-vs-Asian |
6.476300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.39568389967826E-14 |
| Normal-vs-Female |
5.49471579347482E-12 |
| Male-vs-Female |
6.082400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.01439967536976E-11 |
| Normal-vs-Age(41-60Yrs) |
3.44169137633799E-15 |
| Normal-vs-Age(61-80Yrs) |
5.28620036632788E-10 |
| Normal-vs-Age(81-100Yrs) |
1.63610000003533E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.787400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.793700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.382400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.910210E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.129200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.171600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.419900E-03 |
| Normal-vs-Grade 2 |
8.62643290133747E-14 |
| Normal-vs-Grade 3 |
3.15830028796427E-10 |
| Normal-vs-Grade 4 |
8.09352584951739E-14 |
| Grade 1-vs-Grade 2 |
3.535400E-01 |
| Grade 1-vs-Grade 3 |
3.354800E-01 |
| Grade 1-vs-Grade 4 |
1.059160E-01 |
| Grade 2-vs-Grade 3 |
8.103400E-01 |
| Grade 2-vs-Grade 4 |
1.973360E-01 |
| Grade 3-vs-Grade 4 |
5.363600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.65234492754962E-12 |
| Normal-vs-ccB subtype |
1.62569957495862E-12 |
| ccA subtype-vs-ccB subtype |
1.486760E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.25909982229678E-10 |
| Normal-vs-N1 |
1.52647999999145E-05 |
| N0-vs-N1 |
3.630200E-01 |
|
|
